Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells

Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells

Immune checkpoint blockade (ICB) therapy targeting the programmed death ligand-1 (PD-L1)/PD-1 axis has emerged as a promising treatment for uterine cervical cancer; however, only a small subset of patients with uterine cervical squamous cell carcinoma (SCC) derives clinical benefit from ICB therapie...

Full description

Bibliographic Details
Main Authors: Rina Doukuni, Takuro Kobori, Chihiro Tanaka, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
programmed death ligand-1
ezrin/radixin/moesin
uterine cervical squamous cancer
immune checkpoint inhibitor
cancer immunotherapy
Online Access:https://www.mdpi.com/2077-0383/11/13/3830

Internet

https://www.mdpi.com/2077-0383/11/13/3830

Similar Items